| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President and CEO
1 company
R. Erik Holmlin is President and CEO at BNGO. R. Erik Holmlin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2K at current prices.
Net of sales, the BNGO filings show accumulation of 21,655 shares.
R. Erik Holmlin has 19 Form 4 filings on record from August 2018 to February 2026, all as President and CEO at Bionano Genomics (BNGO), 2018–2026.
The 26 reported transactions were 9 option or other derivative awards, 7 tax withholdings, 6 open-market purchases and 4 stock awards.
Counted by filing, the open-market trades come to 3 purchases worth about $40K and no sales.
The largest open-market purchase was 5,025 shares of BNGO at an average $3.99 on November 29, 2021, about $20K. Twelve months later BNGO was down 52%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | BNGO Bionano Genomics, Inc. | President and CEO | Buy | 15,000 | $0.64 | $9,639.00 | +1.9% | -47.2% | -82.5% | |
| Nov 29, 2021 | BNGO Bionano Genomics, Inc. | President and CEO | Buy | 5,025 | $3.99 | $20,037.25 | New | -45.5% | -51.7% | |
| Aug 23, 2018 | BNGO Bionano Genomics, Inc. | President and CEO | Buy | 1,630 | $6.13 | $9,983.75 | New | - | - |